Blog Archives

Since 2004, the Dr. Paul Janssen Award for Biomedical Research has honored scientists who have made a transformational contribution toward the improvement of human health. This prestigious award honors the legacy of Dr. Paul Janssen, an exceptionally gifted and passionate scientist who revolutionized modern medicine and inspired a new generation of researchers.

This half-day virtual symposium will celebrate the 2023 Honoree, Dr. Robert Langer, and his pioneering work. You can learn more about Dr. Langer below. We are proud to offer this event free of cost to anyone interested in celebrating scientific innovation. Registration is required.

Sponsors

Presented by

Sponsored by

This three-day meeting will convene immuno-oncology experts across academia and industry to share cutting-edge discoveries and to advance the development of novel cancer immunotherapies.

Global experts explore the gene regulation of hemoglobin; the pathophysiology of iron overload, clinical management, emerging therapies, co-morbidities, and updates from clinical trials using gene addition, gene editing, and alternative donor source hematopoietic stem cell transplantation, among other topics central to thalassemia syndromes.

This two-day conference will convene leaders in vaccinology, virology, immunology, biotechnology, microbiology, systems biology, and health policy. Session topics include a look back at advances in vaccine development, updates from present-day vaccinology, a discussion on how vaccine development can be strengthened based on COVID-19 vaccine learnings, pharma company pipeline updates, next generation vaccine adjuvants, improving immune measures, and more.

Researchers are opening up new avenues in our understanding of pain. This symposium will explore dissection of central pain circuits, genetics, biomarkers, emerging therapies, neuro-immune and auto-immune mechanisms, sex and ethnic differences, and innovations in the identification and development of new therapeutic targets for pain.

This symposium will bring together experts in proteostasis biology and neurodegenerative disease, along with clinicians, drug developers, and investors to discuss emerging therapies targeting proteostasis pathways to treat neurodegenerative disease.

Our genomes are composed of the sum total of genetic material necessary to encode the blueprint for human life. The effective maintenance of genome integrity and stability is essential for normal cell division, normal function of our tissues and organs, healthy aging, and the prevention of diseases such as cancer. The processes that regulate genome integrity maintenance include sensing, signaling, and repair of DNA damage, processing of DNA damage in the context of chromatin and chromosomes, cell cycle checkpoint control, and control of cell death. Many of the basic aspects of genome integrity—such as how cells sense and process DNA damage—are still not well understood.

Our portfolio of events and publications in Genome Integrity seek to successfully map the mechanisms by which these regulatory processes act or go awry, presenting an exciting avenue for identifying novel approaches for protecting against disease-causing errors and restoring function.